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Many herpesviruses bind to heparan sulfate (HS). Murid herpesvirus-4 (MuHV-4) does so via
its envelope glycoproteins gp70 and gH/gL. MuHV-4 gp150 further regulates an HS-
independent interaction to make that HS-dependent too. Cell binding by MuHV-4 virions is
consequently strongly HS-dependent. Gp70 and gH/gL show some in vitro redundancy: an
antibody-mediated blockade of HS binding by one is well tolerated, whereas a blockade of both
severely impairs infection. In order to understand the importance of HS binding for MuHV-4 in
vivo, we generated mutants lacking both gL and gp70. As expected, gL
”gp70
” MuHV-4
showed very poor cell binding. It infected mice at high dose but not at low dose, indicating
defective host entry. But once entry occurred, host colonization, which for MuHV-4 is relatively
independent of the infection dose, was remarkably normal. The gL
”gp70
” entry deficit was
much greater than that of gL
” or gp70
” single knockouts. And gp150 disruption, which allows
HS-independent cell binding, largely rescued the gL
”gp70
” cell binding and host entry deficits.
Thus, it appeared that MuHV-4 HS binding is important in vivo, principally for efficient host
entry.
INTRODUCTION
Viruses must bind to cells to infect them. The binding
specificities of herpesvirus glycoproteins should therefore
be major determinants of tropism. Many herpesviruses
bind to heparan sulfate (HS) (Shukla & Spear, 2001;
Spillmann, 2001). The low affinities of some viral HS
binding and its commonality between viruses with different
tropisms have led to the idea that HS provides only non-
specific virion adsorption, and is much less important for
tropism than protein receptor engagements (Spillmann,
2001). However, some HS binding has high affinity (Rux
et al., 2002), and the high valencies of both cells and virions
should make even low-affinity binding essentially irrevers-
ible. HS binding may therefore be an important determin-
ant of how a virus colonizes its host.
Herpesviruses commonly express multiple HS-binding
glycoproteins. For example, herpes simplex virus binds to
HS via gB, gC and gD (Shukla & Spear, 2001), with some
redundancy between gB and gC (Herold et al., 1994;
Laquerre et al., 1998). Among the rhadinoviruses, murid
herpesvirus-4 (MuHV-4) and the Kaposi’s sarcoma-
associated herpesvirus (KSHV) each has at least two HS-
binding glycoproteins. MuHV-4 binds to HS via gp70 and
gH/gL (Gillet et al., 2007a, 2008a); KSHV does so via K8.1
(Birkmann et al., 2001; Wang et al., 2001), its gp70
homologue (Mark et al., 2006), and possibly also gB (Akula
et al., 2001).
The MuHV-4 K8.1 homologue, gp150, has a more
unusual HS interaction than simple binding. It binds to
HS at best weakly (Gillet et al., 2007a). Whilst wild-type
(wt) MuHV-4 infection is highly HS-dependent, gp150
knockouts are hardly HS-dependent at all; for example
they are 1000-fold less sensitive to inhibition by soluble
heparin (de Lima et al., 2004; Gillet et al., 2007a).
Gp150
2 mutants are also relatively unaffected by
antibody blocks to gH/gL and gp70 HS-binding (Gillet
et al., 2008a). Since gp150 mutants specifically gain
binding to HS-deficient targets, gp150 must normally
inhibit HS-independent cell binding. The weak HS
interaction of gp150 presumably allows it to be displaced
from its inhibitory site only when virions are already
bound to cells, that is, after HS engagement by gH/gL or
gp70 (Gillet et al., 2008a). Thus, MuHV-4 cell binding, as
studied in vitro, is entirely HS-dependent. Gp150
2
virions are defective mainly in release from infected cells.
This corresponds to infected cells having reduced HS
expression (de Lima et al., 2004): gp150
+ virions readily
escape, but gp150
2 virions cannot.
Although HS binding is important for many herpesviruses
in vitro, there has been little analysis of its importance in
vivo. Removing HS from the host is technically difficult.
The alternative strategy pursued here was to remove HS-
binding proteins from the virus – the gH/gL and gp70 of
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not; it is essential only for gH to adopt its HS-binding
conformation (Gill et al., 2006; Gillet et al., 2007b). gL
disruption therefore removes gH/gL-dependent HS-bind-
ing without rendering virions non-infectious. Gp70 func-
tions in complement evasion (Kapadia et al., 1999) as well
as HS-binding, but is also non-essential (Adler et al., 2000;
Kapadia et al., 2002). In contrast to gL
2 and gp70
2 single
knockouts, MuHV-4 lacking both was severely impaired
for cell binding and host entry. Both deficits were relieved
by disrupting gp150. A major function of MuHV-4 HS
binding is therefore to promote host entry.
METHODS
Mice. Female C57BL/6 mice (Harlan UK Ltd) were infected
intranasally with MuHV-4 when 6–8 weeks old (Home Office
Project Licence 80/1992), using 300 plaque-forming units (p.f.u.)
unless stated otherwise.
Cells. Hamster kidney (BHK-21) fibroblasts, NIH-3T3-CRE fibro-
blasts (Stevenson et al., 2002) and NMuMG epithelial cells were
grown in Dulbecco’s modified Eagle medium supplemented with
2 mM glutamine, 100 U penicillin ml
21, 100 mg streptomycin ml
21
and 10% fetal calf serum (complete medium).
Viruses. All viruses were derived from an MuHV-4 bacterial artificial
chromosome (BAC) (Adler et al., 2000). Established mutations of gL
(Gillet et al., 2007b) and gp70 (Adler et al., 2000; Gillet et al., 2007a)
were combined by introducing the gL
2DEL
2STOP mutation into the
gp70
2 BAC. This disrupted the gL coding sequence (genomic co-
ordinates 65437–65024 of the murine herpesvirus 68 strain GenBank
accession no. U97553) by deleting 65362–65437 and inserting in the
same site of stop codons plus an EcoRI restriction site; the gp70
coding sequence (genomic co-ordinates 9873–11039) was disrupted
by deleting 9954–10984 and inserting an EcoRI restriction site. We
generated two independent double mutants. One was further
modified by introducing the M7
2STOP mutation (de Lima et al.,
2004) to make a gL
2gp70
2gp150
2 triple mutant. Thus, stop codons
plus an EcoRI site were inserted in an AfeI site (69473) of the gp150
coding sequence (69466–70917). We also used an MluI–BglII
genomic clone (Adler et al., 2000) to revert the gp70 locus of the
gL
2gp70
2 mutant BAC, thereby making it a single mutant
(gL
2REV). Infectious virus was reconstituted by transfecting BAC
DNA into BHK-21 cells. For in vivo experiments, the loxP-flanked
BAC/enhanced green fluorescent protein (eGFP) cassette was
removed by passaging viruses through NIH-3T3-CRE cells. Virus
stocks were grown in BHK-21 cells (May et al., 2005a). Cell debris was
pelleted by low speed centrifugation (400 g, 10 min) and virions were
recovered from the infected cell supernatants by ultracentrifugation
(30000 g, 90 min). For some experiments, the virions were further
purified by density-gradient centrifugation (May et al., 2005a). This
made no difference to the results.
Viral infectivity assays. Virus stocks were titrated by plaque assay
(de Lima et al., 2004). BHK-21 cell monolayers were incubated with
virus dilutions (4 h, 37 uC), overlaid with 0.3% carboxymethylcellu-
lose, then 4 days later fixed in 4% formaldehyde and stained with
0.1% toluidine blue. We did not remove the input virus, so as to
detect gL
2gp70
2 virions with maximum sensitivity by giving them
maximum time to establish infection. When the input was removed
after 2 h, gL
2gp70
2 plaque titres were markedly reduced. Infectious
virus in lungs was measured by freezing and thawing the lungs and
homogenizing them in complete medium. Tissue debris was pelleted
(1000 g, 1 min) and homogenate supernatants were titrated by
plaque assay. Latent virus was measured by infectious centre assay (de
Lima et al., 2004): single-cell suspensions of spleens or mediastinal
lymph nodes were co-cultured with BHK-21 cell monolayers, which
were fixed and stained for plaque counting after 4 days. The plaque
assay titres of freeze–thawed lymphoid tissue homogenates were
always ,1% of infectious centre assay titres.
Viral genome quantification. MuHV-4 genomic co-ordinates
4166–4252 were amplified by real-time PCR of DNA extracted from
mouse spleens (Rotor Gene 3000; Corbett Research). The PCR
products were quantified by hybridization with a fluorescent probe
matching genomic coordinates 4219–4189 and converted to genome
copies by comparison with a standard curve of plasmid template
amplified in parallel. Adenosine phosphoribosyltransferase mRNA
was quantified as a cellular control (forward primer 59-GGGGCA-
AAACCAAAAAAGGA-39, reverse primer 59-GCTGGAATTACCGC-
GGCT-39, probe 59-CGCAAATTACCCACTCCCGACCC-39).
Southern blotting. Viral DNA was extracted by alkaline lysis (de
Lima et al., 2004), digested with restriction endonucleases, electro-
phoresed and transferred to nylon membranes (Roche Diagnostics). A
[
32P]dCTP-labelled probe (APBiotech) was generated by random
primer extension (DECAprime II kit; Ambion) of cloned MuHV-4
genome segments (Efstathiou et al., 1990). Membranes were
hybridized with probe (65 uC, 18 h), washed to a stringency of
30 mM sodium chloride/3 mM sodium citrate/0.1% SDS at 65 uC
and exposed to X-ray film.
ELISA. Maxisorp ELISA plates (Nalgene Nunc) were coated (18 h,
4 uC) with 0.05% Triton X-100-disrupted MuHV-4 virions. Plates
were washed three times with PBS 0.1% Tween-20, blocked with
PBS 0.1% Tween-20 1% BSA, incubated with serum dilutions (1 h,
room temperature), washed four times, incubated with alkaline
phosphatase-conjugated goat anti-mouse IgG pAb, washed five times
and developed with nitrophenylphosphate substrate (Sigma-
Aldrich). The reaction was terminated with NaOH and the
absorbance read at 405 nm (Bio-Rad Benchmark ELISA plate
reader).
Monoclonal antibodies (mAbs). We used the following mAbs: 3F7,
anti-gN IgG2a (May et al., 2005b); 7E5, anti-gH/gL IgG2a; T2C12,
anti-gH/gL IgG2a; 8C1, anti-gH IgG2b (Gill et al., 2006); LT-6E8, anti-
gp70 IgG2b (Gillet & Stevenson, 2007a); LT-4D11, anti-gp70 IgG2a
(this study); T1A1, anti-gp150 IgG2a; T4G2, anti-gp150 IgG2a (Gillet
et al., 2007d); BH-6H2, anti-gp150 IgG1 (this study); MG-4D11, anti-
gB IgG2a; MG-12B8, ORF65 capsid component IgG2a (Gillet et al.,
2006); 150-7D1, anti-ORF17 capsid component IgG2a (Gillet &
Stevenson, 2007b); 6D10, anti-gp48 IgG2a (May et al., 2005c).
Immunoblotting. Virions were denatured (95 uC, 5 min) in
Laemmli’s buffer, resolved by SDS-PAGE and proteins transferred
to PVDF membranes (de Lima et al., 2004). The membranes were
probed with MuHV-4-specific mAbs plus horseradish peroxidase-
conjugated rabbit anti-mouse IgG pAb (Dako Cytomation), followed
by enhanced chemiluminescence substrate development (APBiotech).
Flow cytometry. Cells exposed to eGFP
+ viruses were trypsinized,
washed in PBS and analysed for green channel fluorescence. For
surface staining, cells were incubated (1 h, 4 uC) with MuHV-4
glycoprotein-specific mAbs followed by Alexa 633-conjugated or
Alexa 488-conjugated goat anti-mouse pAb (Invitrogen). For
intracellular staining, cells were fixed in 1% paraformaldehyde
(30 min, room temperature) and permeabilized with 0.1% saponin
before staining. Cells were analysed on a FACSort using CellQuest
(Becton Dickinson).
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washed three times in PBS, fixed in 4% paraformaldehyde,
permeabilized with 0.1% Triton X-100, and stained with MuHV-4-
specific mAbs plus Alexa 488-conjugated goat anti-mouse IgG pAb
(Invitrogen). Fluorescence was visualized with an Olympus IX70
microscope plus a Retiga 2000R camera line (QImaging).
RESULTS
Generation of MuHV-4 lacking both gL and gp70
A MuHV-4 BAC mutated for gp70 was modified further
by disrupting the gL and gp150 coding sequences
( F i g .1 a ) .S o u t h e r nb l o ta n a l y s e s( F i g .1 b )d e m o n s t r a t e d
that the viruses generated contained the desired genomic
changes. Flow cytometry of infected cells (Fig. 1c)
confirmed an absence of gp70 or gL expression in the
cells infected with the gL
2gp70
2 double mutant.
Although gL
2gp70
2 mutants were viable, they replicated
poorly in BHK-21 cells: virus stocks typically required
2–3 weeks to grow rather than 4–5 days. The weak
surface gN and gH staining of cells infected with
MuHV-4 gL
2gp70
2 (Fig. 1c) was consistent with poor
infectivity. It also suggested poor cell binding, as virions
bound on the plasma membrane probably account for
much of the virion antigen detected on infected cells (de
Lima et al., 2004). There was no sign of gL
2gp70
2
mutants containing less gN than the wt (see Figs 2c and
6a), so there did not appear to be a general problem with
virion assembly or export.
Wild-type MuHV-4 is readily inhibited by soluble heparin,
presumably because this competes with cellular HS for
binding to gH/gL and gp70 (Gillet et al., 2008a). The
gL
2gp70
2 mutant, lacking HS binding, was accordingly
less sensitive to such inhibition (Fig. 1d). What inhibition
there was presumably reflected the role of HS in displacing
virion gp150 (de Lima et al., 2004; Gillet et al., 2007a,
2008a). This function was evidently less sensitive to
inhibition by soluble heparin than were gH/gL-dependent
or gp70-dependent HS binding, consistent with the
inhibition of wt infection by heparin being mainly an
inhibition of cell binding (Gillet et al., 2008a).
Poor cell binding by gL
”gp70
” MuHV-4
Although gL
2gp70
2 MuHV-4 could form plaques, infec-
tion was clearly delayed relative to wt. Assays of viral eGFP
expression at 24 h post-infection (p.i.) showed a marked
gL
2gp70
2 deficit compared with wt or single-gene mutants
(Fig. 2a). eGFP expression was used to measure infection
because it is independent of MuHV-4 lytic gene expression
(Smith et al., 2007), which can be variable (May et al.,
2004), and because it operates over 4–6 h rather than
4 days, making it intrinsically better at detecting infection
delays. There was no evidence of eGFP expression under-
recording gL
2gp70
2 infection, as infected cultures always
contained more eGFP
+ cells than glycoprotein
+ cells.
NMuMG cells were infected poorly by both gL
2 and
gL
2gp70
2 mutants, indicating that for this cell type the
deficit was mainly gL-dependent. But BHK-21 cells showed
only twofold less infection for the gL
2 and gp70
2 single
mutants compared with wt, and more than 100-fold less
for gL
2gp70
2 mutant.
MuHV-4 gL knockouts have a cell-binding deficit mainly
for BHK-21 cells (Gillet et al., 2007b); their poor infection
of NMuMG cells reflects instead a post-binding entry
deficit (Gillet et al., 2008b). We therefore used NMuMG
cells to define the effect on cell binding of a combined gL/
gp70 disruption (Fig. 2b). The cells were incubated with
virions for 2 h at 4 uC, washed three times with PBS, then
either fixed immediately or first incubated for a further 2 h
at 37 uC to allow endocytosis and virion uncoating. The
fixed, permeabilized cells were then stained for gN to
quantify total virion binding (bound virions still at the cell
surface plus bound virions that were subsequently
endocytosed). This assay measures only virion binding/
uptake, as new glycoprotein expression is undetectable at
4 h p.i. (Gill et al., 2006). The gN staining of the gL
2gp70
2
mutant was much reduced, while that of the gL
2 and
gp70
2 single mutants was close to wt.
Binding was tested further using virus stocks normalized by
immunoblot for gB, gN and the ORF17 capsid component
rather than by plaque titre. A sample immunoblot showing
approximately equal inputs is shown in Fig. 2(c)
(gL
2gp70
2 stocks had at most a threefold increase in
Fig. 1. Generation of MuHV-4 mutants. In order to ablate expression, translational stop codons were inserted into the coding
sequences of gL, gp70 and gp150 as indicated. Single gL and gp70 mutants have been described previously. (a) For this
study, we combined gL and gp70 mutations, and then made a triple mutant by further disrupting gp150. (b) Viral DNA was
analysed by Southern blotting, exploiting the novel EcoRI site introduced during mutagenesis. Wild-type (wt) and gp70
” viruses
provide comparisons. gL
”gp70
”.1 and gL
”gp70
”.2 are independent mutants. For gL, there is a 3.1 kb invariant band and a
942 bp wt band that changes to 270 bp+595 bp. For gp70, a 12.7 kb wt band changes to 3.4 kb+8.4 kb. The 3.4 kb band
was evident by ethidium bromide staining (data not shown), but not by hybridization because it overlaps the probe by only
115 bp. For gp150, a14.9 kb wt band changes to 11.2 kb+3.8 kb. (c) BHK-21 cells were left uninfected (UI) or infected
(2 p.f.u. cell
”1) with wt (18 h infection), single mutant (gL
”, gp70
”, 18 h infections) or double mutant viruses (gL
”gp70
”,6 6h
infection), then analysed by flow cytometry for surface expression of virion glycoproteins. (d) BHK-21 cells were exposed to
BAC
+ wt (1 p.f.u. cell
”1)o rg L
”gp70
” (5 p.f.u. cell
”1) viruses plus soluble heparin. Both viruses expressed eGFP from an
HCMV IE1 promoter, and infection was quantified by flow cytometry after 24 h. Different virus doses were used to ensure
comparable eGFP expression. The difference in susceptibility to heparin was much greater than the difference in virus input.
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”gp70
” MuHV-4 shows a severe deficit in cell binding. (a) BHK-21 or NMuMG cells were exposed to viruses (1 p.f.u.
cell
”1,3 76C) for different times, then washed three times with PBS to remove unbound virions. After 24 h, all cells were
analysed by flow cytometry for viral eGFP expression. Each point shows 210
4 cells. (b) NMuMG cells were exposed to wt or
mutant viruses (2 h, 4 6C, 5 p.f.u. cell
”1), then washed three times with PBS and either fixed immediately (4 6C) or first
incubated in complete medium (2 h, 37 6C). All the cells were then stained for gN, an abundant component of the virion
envelope. New gN expression is not evident until at least 6 h p.i., so this assay detects only input virus. (c) Virus stocks were
compared by immunoblot for gB (mAb MG-4D11), ORF17 (mAb 150-7D1) and gN (mAb 3F7). gB-FL, full-length gB; gB-C,
C-terminal cleavage product. ORF17 is auto-cleaved and so appears as a doublet. (d) NMuMG cells were exposed to wt or
mutant viruses (2 h, 37 6C, 3 p.f.u. cell
”1), then washed three times with PBS and analysed for virion binding by fixation,
permeabilization and staining for gB or gN. nil, No virus. Each bar shows 210
4 cells. Fixation/permeabilization was used to
make virion detection independent of endocytosis.
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21, confirming that the plaque
assay provided a reasonably sensitive measure of gL
2gp70
2
infectivity). NMuMG cells were incubated with virions for
2 h at 37 uC, then washed three times in PBS, fixed,
permeabilized and stained for virion uptake with mAbs
MG-4D11 (gB) and 3F7 (gN) (Fig. 2d). Again, cell binding
by the gL
2gp70
2 double mutant was hardly detectable,
whereas that of the single mutants was relatively unim-
paired.
Infection of mice with MuHV-4 lacking both gL
and gp70
Gp70 disruption has been linked to a lytic replication
deficit after intracerebral or intraperitoneal MuHV-4
inoculation (Kapadia et al., 2002). However, intranasal
infection has not been studied, and the gp70 mutant used
here has been characterized only in vitro (Adler et al.,
2000). Before analysing the gL
2gp70
2 mutant, therefore,
we tested the gp70
2 single mutant for host colonization
after intranasal inoculation (Fig. 3). Lytic replication was
measured by plaque assay of lungs at 6 days p.i.; latency
establishment was measured by infectious centre assay of
mediastinal lymph nodes at 6 days p.i. (seeding) and of
spleens at 13 days p.i. (peak titres). The gp70
2 mutant
showed reduced lytic replication in the lung, reduced
seeding to lymph nodes, and reduced peak latency titres in
the spleen. These results did not distinguish the gp70
functions of complement evasion and HS binding, but
established that gp70 disruption alone causes a moderate
defect in host colonization by the intranasal route. We have
shown before that intranasally delivered gL
2 MuHV-4
spreads and establishes latency much like wt (Gillet et al.,
2007b).
We then infected mice with gL
2gp70
2 MuHV-4 and
compared its replication with wt (Fig. 4a). Surprisingly,
there was only a deficit in lytic replication, and this was no
greater than with the gp70
2 single mutant. The latent viral
load in mediastinal lymph nodes and spleens was normal.
gL
2gp70
2 viruses recovered from infected lungs appeared
to grow better in vitro than the original mutant (data not
shown). We therefore propagated these viruses further and
analysed them for glycoprotein expression (Fig. 4b). BHK-
21 cells were infected with either the gL
2gp70
2 viruses
recovered from infected lungs (L1-L5) or with wt MuHV-4
as a control. As cells infected with wt express all virion
glycoproteins more strongly than those infected with
gL
2gp70
2 mutants (Fig. 1c), we measured each glycopro-
tein by the number of positively staining cells compared
with the number positive for gN, an essential virion
component. There was no sign of the L1-L5 mutants
regaining gL or gp70 expression, but each showed much
reduced gp150 expression.
DNA sequence analysis established that the gp150-coding
sequence of the recovered viruses (genomic co-ordinates
69466–70917) was disrupted by a deletion of co-ordinates
70020–70847 and the insertion of co-ordinates 91761–
Fig. 3. In vivo replication of gp70
” MuHV-4 after intranasal
inoculation. Mice were infected intranasally (300 p.f.u.) with wt,
gp70
” or revertant (gp70
+) viruses, then analysed for infectious
virus in lungs by plaque assay and for latent virus in lymphoid tissue
by infectious centre assay. Each point shows the titre of one
mouse. gp70
” virus titres in lungs and spleens were significantly
reduced compared with wt (P,0.001 by Student’s t-test).
Although the gp70
” mediastinal lymph node titres were also
lower, the difference did not reach statistical significance
(P50.06).
MuHV-4–HS interactions in vivo
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was terminated upstream of its membrane anchor. The
same mutation was present in all mice, and was found to be
a minor contaminant of the BAC
2 inoculating virus, but
not the BAC
+ parent analysed in Figs 1 and 2. Thus, it
arose during gL
2gp70
2 virus passage in NIH-3T3-CRE
cells and was then strongly selected during in vivo infection
and ex vivo virus recovery. It was not visible (a predicted
722 bp deletion of the 14.9 kb wt EcoRI band) in the
gL
2gp70
2.1 Southern blot of Fig. 1(b). The outgrowth of
the gL
2gp70
2gp150
2 mutant supported the idea that
gL
2gp70
2 mutants were attenuated due to a loss of HS
binding, as removing gp150 offsets such a loss (Gillet et al.,
2008a).
Comparison of gL
”gp70
” and gL
”gp70
”gp150
”
MuHV-4 mutants
In order to identify more definitively the gL
2gp70
2 in vivo
phenotype and the impact on it of gp150 disruption, we
compared a second gL
2gp70
2 mutant with no evidence of
gp150 disruption (gL
2gp70
2.2) with both wt MuHV-4 and
a deliberately designed gL
2gp70
2gp150
2 triple mutant
(Fig. 5). The triple mutant grew much better in vitro than
either the gL
2gp70
2.2 mutant or the BAC
+ form of
gL
2gp70
2.1, which retained gp150 (Fig. 5a). Flow
cytometry of the infected cultures after 1 week (Fig. 5b)
established that both gL
2gp70
2 mutants remained
gp150
+: the number of gp150
+ cells was equivalent to
the number of gN
+ cells. Cell-binding experiments
(Fig. 5c) similar to those in Fig. 2 established that
gL
2gp70
2gp150
2 MuHV-4 was much less impaired for
cell binding than its gL
2gp70
2 parent. Removing gp150
therefore improved markedly both the cell binding and the
in vitro propagation of gL
2gp70
2 MuHV-4.
In vivo comparison of gL
”gp70
” and
gL
”gp70
”gp150
” MuHV-4
We then analysed a BAC
2 form of the gL
2gp70
2.2 mutant
in vivo (Fig. 6). The gp150 coding sequence of this mutant
was confirmed as wt by PCR and sequencing of viral DNA.
Immunoblots of virion lysates (Fig. 6a) showed that the
gL
2gp70
2 mutant stock had approximately three times the
Fig. 4. In vivo infection with gL
”gp70
” MuHV-4. (a) Mice were infected intranasally (300 p.f.u.) with wt or gL
”gp70
” MuHV-4,
then analysed for infectious virus in lungs by plaque assay and for latent virus in lymphoid tissue by infectious centre assay. Each
point shows the titre of one mouse. gL
”gp70
” titres were significantly lower than wt in lungs at day 6 (P,0.001 by Student’s t-
test) but not in lymphoid tissue. (b) gL
”gp70
” viruses from the individual mouse lungs in (a) (L1-L5) were propagated in BHK-
21 cells for 7 days then analysed for glycoprotein expression by flow cytometry. Cells were scored as stained or not, based on a
gate excluding .99% of uninfected cells. Uninfected (UI) and wt virus-infected (wt) BHK-21 cells provided controls. Each bar
shows 210
4 cells. For equivalent gN expression, gp150 expression by the gL
”gp70
” knockouts was significantly reduced
compared with wt (P,10
”5 by x
2 test).
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but for an equivalent amount of ORF17 (capsid) or gN, the
gp150 content of wt and gL
2gp70
2 mutant viruses was
similar. Therefore, there was no sign of the gL
2gp70
2.2
mutant being rescued by spontaneous gp150 loss.
As with the gL
2gp70
2.1 mutant, the gL
2gp70
2.2 mutant
showed an acute lytic replication deficit in infected lungs
(Fig. 6b). It also showed a latency deficit in lymphoid
tissue, like the original gp70 single knockout (Fig. 3),
whereas gL
”gp70
+ and gL
”gp70
”gp150
” viruses did not
(thus, the lack of a latency deficit for the gL
2gp70
2.1
mutant could be attributed to the spontaneous loss of
gp150). Interestingly, two out of five gL
2gp70
2.2-exposed
mice showed no detectable infection by infectious centre
assay at 13 days. Similar results were obtained by real-time
PCR of viral genomes (Fig. 6c), indicating that the lack of
detectable infection was a failure of host colonization
rather than a failure of ex vivo reactivation.
Recovered gL
”gp70
” viruses again show evidence
of gp150 loss
We again analysed the glycoprotein expression of viruses
recovered from infected lungs (Fig. 6d). Although gp150
Fig. 5. In vitro growth of gL
”gp70
” MuHV-4. (a) BHK-21 cells were infected (0.01 p.f.u. cell
”1) with eGFP-expressing forms of
each virus, then monitored by flow cytometry of eGFP expression. Each point shows 210
4 cells. (b) gL
”gp70
” infected cells
from (a) were then analysed for viral glycoprotein expression. Cells uninfected (UI) or infected overnight with wt MuHV-4
(1 p.f.u. cell
”1) provided controls. For both the gL
”gp70
” mutants, gp150 expression was equivalent to gN expression. (c)
BHK-21 cells were exposed to virus stocks normalized by immunoblot (2 h, 37 6C). The equivalent infectivity for wt was 3 p.f.u.
(100%) or 0.6 p.f.u. (20%). The cells were washed three times with PBS to remove unbound virions, fixed, permeabilized and
stained for gN or gB. The horizontal dashed lines show the fluorescence of uninfected cells analysed in parallel. Each bar shows
the result for 210
4 cells. Uptake of the gL
”gp70
”gp150
” mutant was significantly higher than the gl
”gp70
” mutant even with
1/5 the input (P,10
”5 by Student’s t-test).
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”gp70
”gp150
+ MuHV-4. (a) The gL
”gp70
”.2 mutant was analysed for gp150 content by immunoblot
with mAbs that recognize gp150 residues 152–269 (T1A1) or 108–151 (T4G2) (Gillet et al., 2007d). gN and the ORF17 capsid
componentprovidedloadingcontrols.The62 kDabandintheT4G2+3F7immunoblotofthegL
”gp70
”stockisnon-specificstainingof
bovine albumin. Because gL
”gp70
” stocks had lower titres than wt, more albumin was present at comparable infectivity. (b) Mice were
infectedintranasally(300 p.f.u.)with wtor gL
”gp70
”virusesanalysedin (a),then titratedforinfectiousvirus in lungsby plaqueassayand
for latent virus in lymphoid tissue by infectious centre assay. Each point shows the titre of one mouse. The horizontal dashed lines show
lowerlimitsofdetection.gL
”gp70
”,butnotgL
”gp70
”gp150
”virustitresweresignificantlylowerthanwtinallsites(P,0.01byStudent’s
t-test). (c) DNA was extracted from the spleens in (b) and viral genome copy numbers determinedby real-time PCR.Each bar shows the
average of triplicate reactions. The horizontal dashed line shows the average of three uninfected controls. (d) gL
”gp70
” viruses were
recovered from infected lungs by propagation in BHK-21 cells for 14 days, then analysed for virion glycoprotein expression by flow
cytometry. BHK-21 cells either uninfected or infected overnight with wt MuHV-4 (1 p.f.u. cell
”1, 18 h), provided staining controls. nil,
Secondary antibody only. Each bar shows 210
4 cells. mAbs T4G2, T1A1 and BH-6H2 recognize different gp150 epitopes.
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”gp70
” virus had been normal
(Figs 5b, 6a), that of the recovered viruses was again
reduced. The degree of reduction varied between gp150-
specific mAbs, but each showed fewer positive cells than
gN-specific and gp48-specific mAb controls, whereas for wt
the numbers were similar. This time, the gp150 coding
sequence and its upstream 50 bp were entirely normal by
PCR and DNA sequencing. There may have been changes
in other virion components to reduce gp150 incorporation.
Whatever the mechanism, it was clear that a lack of gL and
gp70 strongly selected for gp150 loss.
gL
”gp70
” MuHV-4 shows reduced host entry
Viruses are selected by their capacity to transmit, so a key
parameter of evolutionary fitness is efficient entry into
naive hosts. Wild-type MuHV-4 productively infects mice
after intranasal inoculation of 1 p.f.u. (Gillet et al., 2007c).
The failure of some mice to become detectably infected after
exposure to 300 p.f.u. of the gL
2gp70
2 mutant therefore
suggested that HS binding might have an important role in
host entry. To establish this more definitively, we tested
whether low dose gL
2gp70
2 inoculations established
infection (Fig. 7a). Approximately 100 times more
gL
2gp70
2 virus than wt was required.
We then compared the gL
2gp70
2 mutant with gp70
2 and
gL
2 single mutants and with the gL
2gp70
2gp150
2 triple
mutant (Fig. 7b). Again, 100-fold more gL
2gp70
2 virus
than wt was required to establish infection. The gL
2REV
mutant also showed significantly less infection than wt at
1 p.f.u. per mouse, indicating a gL-dependent deficit, but
at 1 p.f.u. gL
2gp70
2 deficit was significantly greater than
that of gL
2 REV, and at 10 p.f.u. only the gL
2gp70
2
infection was significantly less than wt. The gp70
2 mutant
showed no deficit. gp150 disruption completely restored
efficient host entry to the gL
2gp70
2 mutant. The
requirements for host entry therefore mirrored those for
in vitro cell binding: one or more of the virion HS-binding
proteins was required, unless gp150 was also missing.
DISCUSSION
MuHV-4 infection of epithelial cells is highly HS-dependent
(Gillet et al., 2007a). mAb blocking and viral mutagenesis
(Gillet et al., 2008a) show two levels of dependence: first,
virions must attach to HS via either gH/gL or gp70; second,
HS interactions remove theinhibitionthat gp150 exerts over
HS-independent cell binding. The gH/gL and gp70 interac-
tions occur first, as a combined mAb block of gH/gL and
gp70 only modestly affects gp150
2 mutants, but severely
attenuates wt MuHV-4 (Gillet et al., 2008a). These results
predicted that a cell-binding deficit for gL
2gp70
2 mutants
would be offset by disrupting gp150, and in vitro infection
studies supported this hypothesis. Infecting mice with
gL
2gp70
2 and gL
2gp70
2gp150
2 mutants then allowed us
to link HS binding to host colonization. A lack of HS
binding had a limited impact on viral dissemination, which
depends mainly on latency-associated lymphoproliferation
(Coleman et al., 2003; Stevenson et al., 1999), but severely
reduced host entry.
Where might HS binding occur in host entry? Incoming
virions arrive at mucosal epithelia, which carry HS on
Fig. 7. Low dose in vivo infection with gL
” and gp70
” viruses. (a)
The gL
”gp70
”.2 mutant was compared with wt MuHV-4 by
intranasal inoculation of mice with 1–1000 p.f.u. Twelve mice per
group for each dose were scored as infected or not at 16 days p.i.
by infectious centre assay of spleens and by ELISA for virus-
specific serum IgG, with concordant results. The gL
”gp70
”
infection rate was significantly lower than wt at 1–10 p.f.u.
(P,0.005 by Fisher’s exact test), but not at 100 p.f.u. (P50.1).
(b) Virus knockouts were compared with wt for infectivity (12 mice
per group) after intranasal inoculation. The gL
”REV and
gL
”gp70
”gp150
” mutants were derived from the gL
”gp70
”
mutant. Their infectivities were equivalent to wt. The gL
” and
gL
”gp70
” infection rates were both significantly less than wt at
1 p.f.u. (P,0.05 by Fisher’s exact test). Only the gL
”gp70
”
infection rate was significantly lower at 10 p.f.u. (P,0.02). At
1 p.f.u. the gL
”gp70
” infection rate was significantly lower than
that of the gL
” (P,0.01).
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syndecans is more distal to the membrane and therefore
more likely to participate in virion capture. In support of
this, overexpressing syndecan-1 on B cells increases their
susceptibility to MuHV-4 infection (Bennett et al., 2005).
However, syndecan expression is confined to the basolat-
eral side of confluent epithelial cells in vitro (Rapraeger
et al., 1986) and is lost entirely from differentiated
epithelial cells in vivo (Hayashi et al., 1987). Thus, while
virions exiting a host could readily bind to basolateral
epithelial HS, it is far from clear that the same interaction is
available to incoming virions on the apical side. Human
cytomegalovirus shows an HS-dependent restriction of
apical epithelial infection in vitro (Esclatine et al., 2001).
MuHV-4 also infects confluent epithelial monolayers
poorly in vitro (data not shown). Thus, incoming virions
may require epithelial transcytosis, for example via M cells
(Wolf et al., 1981; Morin et al., 1994), to interact with HS.
Transcytosis could also explain how intranasally delivered,
replication-deficient MuHV-4 mutants can infect B cells
(Kayhan et al., 2007; Moser et al., 2006). The MuHV-4
gp150 normally inhibits B cell infection (de Lima et al.,
2004). Its positional homologue in Epstein–Barr virus,
gp350, analogously inhibits epithelial infection; this is
overcome by gp350 binding to B cells (Shannon-Lowe
et al., 2006). The equivalent ‘transfer infection’ for MuHV-
4 would be gp150 displacement by virion binding to
epithelial HS. Thus, incoming MuHV-4 virions could be
transported to the basolateral epithelium by M cells, engage
HS, then either infect the epithelium itself from under-
neath or be transferred to submucosal B cells. Without gH/
gL or gp70, virions would fail to engage epithelial HS, so
the inhibitory effect of gp150 could not be undone, making
host entry inefficient. With gp150 removed (the
gL
2gp70
2gp150
2 mutant), HS engagement might not be
required. The disadvantage of gp150 deficiency, apart from
reduced antibody evasion (Gillet et al., 2007d), would be in
host exit: virions lacking gp150 would be recaptured by
HS-independent binding to the apical epithelium.
The latency deficit of gp70
2, but not gL
2, MuHV-4 after
intranasal infection suggested that the redundancy of gH/
gL and gp70 for epithelial HS-binding might be less
elsewhere. For example, gp70 could have a particular role
in promoting B-cell infection. Syndecan-1 is expressed only
on pro-B cells and plasma cells, neither of which is a major
target for MuHV-4, but syndecan-4 is widely expressed
(Yamashita et al., 1999) and gp70-Fc shows heparin-
dependent binding to B cells (data not shown). A role for
gp70 in B cell infection would be consistent with the lack of
a latency deficit for gL
2gp70
2gp150
2 MuHV-4: gp150
removal is unlikely to compensate for a lack of
complement evasion, but could compensate for a lack of
HS binding (Gillet & Stevenson, 2007b). Thus, it appears
with MuHV-4 that HS interactions are not just a prelude to
specific receptor binding, but rather a fundamental feature
of virion tropism and host entry.
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